Overview

Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants

Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
Study to determine the bioequivalence of a zanubrutinib tablet compared to capsules in healthy adult participants.
Phase:
Phase 1
Details
Lead Sponsor:
BeiGene
Treatments:
Zanubrutinib